These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 38345654)

  • 1. Neuro-ophthalmic complications of modern anti-cancer drugs.
    Oskam JA; Danesh-Meyer HV
    Graefes Arch Clin Exp Ophthalmol; 2024 Jul; 262(7):2269-2281. PubMed ID: 38345654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuro-ophthalmic Complications of Immune Checkpoint Inhibitors: A Systematic Review.
    Yu CW; Yau M; Mezey N; Joarder I; Micieli JA
    Eye Brain; 2020; 12():139-167. PubMed ID: 33173368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuro-ophthalmic sarcoidosis: the University of Iowa experience.
    Koczman JJ; Rouleau J; Gaunt M; Kardon RH; Wall M; Lee AG
    Semin Ophthalmol; 2008; 23(3):157-68. PubMed ID: 18432542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Afferent and Efferent Neuro-Ophthalmic Complications of Coronavirus Disease 19.
    Tisdale AK; Dinkin M; Chwalisz BK
    J Neuroophthalmol; 2021 Jun; 41(2):154-165. PubMed ID: 33935220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuro-ophthalmologic side-effects of systemic medications.
    Pula JH; Kao AM; Kattah JC
    Curr Opin Ophthalmol; 2013 Nov; 24(6):540-9. PubMed ID: 24100367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuro-Ophthalmic Complications in Patients Treated With CTLA-4 and PD-1/PD-L1 Checkpoint Blockade.
    Sun MM; Seleme N; Chen JJ; Zekeridou A; Sechi E; Walsh RD; Beebe JD; Sabbagh O; Mejico LJ; Gratton S; Skidd PM; Bellows DA; Falardeau J; Fraser CL; Cappelen-Smith C; Haines SR; Hassanzadeh B; Seay MD; Subramanian PS; Williams Z; Gordon LK
    J Neuroophthalmol; 2021 Dec; 41(4):519-530. PubMed ID: 33136674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuro-ophthalmic manifestations of cancer: a narrative review.
    Janetos TM; Volpe NJ; Simon SS
    Chin Clin Oncol; 2022 Jun; 11(3):25. PubMed ID: 35818857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collapsin Response-Mediator Protein 5-Associated Retinitis, Vitritis, and Optic Disc Edema.
    Cohen DA; Bhatti MT; Pulido JS; Lennon VA; Dubey D; Flanagan EP; Pittock SJ; Klein CJ; Chen JJ
    Ophthalmology; 2020 Feb; 127(2):221-229. PubMed ID: 31676123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation and test characteristics of a 10-item neuro-ophthalmic supplement to the NEI-VFQ-25.
    Raphael BA; Galetta KM; Jacobs DA; Markowitz CE; Liu GT; Nano-Schiavi ML; Galetta SL; Maguire MG; Mangione CM; Globe DR; Balcer LJ
    Am J Ophthalmol; 2006 Dec; 142(6):1026-35. PubMed ID: 17046704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuro-ophthalmic side effects of molecularly targeted cancer drugs.
    Bhatti MT; Salama AKS
    Eye (Lond); 2018 Feb; 32(2):287-301. PubMed ID: 29052609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuro-ophthalmic complications of immune checkpoint inhibitor therapy: Current status and future directions.
    Winges KM; Gordon LK
    Front Ophthalmol (Lausanne); 2022; 2():1044904. PubMed ID: 38983573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroradiologic Imaging of Neurologic and Neuro-Ophthalmic Complications of Coronavirus-19 Infection.
    Marsiglia M; Chwalisz BK; Maher M
    J Neuroophthalmol; 2021 Dec; 41(4):452-460. PubMed ID: 34788237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ophthalmic complications of immune checkpoint inhibitors.
    Wladis EJ; Kambam ML
    Orbit; 2022 Feb; 41(1):28-33. PubMed ID: 33386059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ophthalmological complications of targeted agents in cancer therapy: what do we need to know as ophthalmologists?
    Ho WL; Wong H; Yau T
    Acta Ophthalmol; 2013 Nov; 91(7):604-9. PubMed ID: 22970709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuro-ophthalmic Complications of Immune-Checkpoint Inhibitors.
    Mukharesh L; Chwalisz BK
    Semin Ophthalmol; 2021 May; 36(4):241-249. PubMed ID: 33641589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients With Migraine Have Substantial Reductions in Measures of Visual Quality of Life.
    Hanson LL; Ahmed Z; Katz BJ; Warner JEA; Crum AV; Zhang Y; Zhang Y; Baggaley S; Pippitt K; Cortez MM; Digre KB
    Headache; 2018 Jul; 58(7):1007-1013. PubMed ID: 29877580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on ocular complications of systemic cancer chemotherapy.
    Schmid KE; Kornek GV; Scheithauer W; Binder S
    Surv Ophthalmol; 2006; 51(1):19-40. PubMed ID: 16414359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neuro-ophthalmology: the eye as a window to the brain].
    Kesler A
    Harefuah; 2013 Feb; 152(2):66-8, 124. PubMed ID: 23513493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuro-Ophthalmic Visual Impairment in the Setting of COVID-19.
    Dinkin M; Sathi S
    Semin Neurol; 2023 Apr; 43(2):268-285. PubMed ID: 37311536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune checkpoint inhibitors: what neuro-ophthalmologists need to know.
    Douglas VP; Douglas KAA; Cestari DM
    Curr Opin Ophthalmol; 2019 Nov; 30(6):426-433. PubMed ID: 31449088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.